SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
October 29, 2021
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
Building 5, Croxley Park,
Hatters Lane, Watford, Hertfordshire, WD18 8YE,
England
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SMITH & NEPHEW PLC
29 October 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
| Reason for the notification |
| Initial notification /Amendment | Initial notification |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| Name | Smith & Nephew plc |
| LEI | 213800ZTMDN8S67S1H61 |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
Description of the financial instrument, type of instrument | Smith & Nephew plc ordinary shares of USD 0.20 each |
| Identification code | ISIN: GB0009223206 |
| Nature of the transaction | Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2021 interim dividend payment on 27 October 2021. |
| Date of Transaction | 2021 - 10 - 27 |
| Place of Transaction | London Stock Exchange (XLON) |
Name (Position) | Director / PDMR | Price | Volume | Aggregated information | Total Ordinary Share Holding following the transaction * | Total Ordinary Share Holding as a % of the Company's ISC following the transaction * |
Bradley Cannon (President Sports Medicine & ENT) | PDMR | £13.06288 | 1.04868 | N/A Single Transaction | 77,922.43852 (including 2,414.63870 in ADS') | 0.00880% |
Phil Cowdy (Chief Business Development & Corporate Affairs Officer) | PDMR | £13.06288 | 83.67835 | N/A Single Transaction | 45,493.96621 | 0.00514% |
Myra Eskes (President APAC Region) | PDMR | £13.06288 | 23.35315 | N/A Single Transaction | 2,928.68131 | 0.00033% |
Simon Fraser (President Advanced Wound Management) | PDMR | £13.06288 | 85.03095 | N/A Single Transaction | 10,663.59428 | 0.00120% |
Skip Kiil (President Orthopaedics) | PDMR | £13.06288 | 74.08913 | N/A Single Transaction | 12,202.12693 | 0.00138% |
Catheryn O'Rourke (Chief Legal & Compliance Officer) | PDMR | £13.06288 | 435.47055 | N/A Single Transaction | 83,240.14924 (including 6,170.31995 in ADS') | 0.00940% |
Susan Swabey (Company Secretary) | PDMR | £13.06288 | 142.14675 | N/A Single Transaction | 49,558.39347 | 0.00560% |
* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.
Susan Swabey
Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Smith & Nephew Plc
(Registrant)
Date: October 29, 2021
By: /s/ Susan Swabey
-----------------
�� Susan Swabey
Company Secretary
